Market Overview

Roche 2012 Net Profit Rises 2%

Related RHHBY
Jefferies Shares Pharma Stock Catalyst Outlook
Has Cancer Research Become Cancerous? Same Cancer Strategy Targeted By 'Too Many Drugmakers,' Say Regulators
Roche Quietly Takes Hemophilia Lead (Seeking Alpha)

Roche Holding AG (OTC: RHHBY) reported a 2% rise in its full-year net profit.

Roche's full-year net profit surged to CHF9.54 billion, versus CHF9.34 billion, in the year-ago period.

Its annual sales climbed 4% to CHF45.5 billion from CHF42.53 billion. However, analysts were expecting a profit of CHF10.03 billion on sales of CHF45.17 billion.

Roche shares closed at $54.98 yesterday.

Posted-In: profitEarnings News


Related Articles (RHHBY)

View Comments and Join the Discussion!